Hakan Öner

Hakan Öner

Auto-generated profile, based on publicly available information

Hakan Öner

Dokuz Eylül University Faculty of Medicine, Department of Ophthalmology, İzmir, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
MKMahmut Kaya
Mahmut Kaya
FÖFerit Hakan Öner
Ferit Hakan Öner
BYBetül Akbulut Yağcı
Betül Akbulut Yağcı
FAFerdane Ataş
Ferdane Ataş
TOTaylan Ozturk
Taylan Ozturk
To evaluate the functional and anatomical results of patients with non-infectious intraocular inflammation (IOI) following intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection for the treatment of neovascular age-related macular degeneration (nAMD). The medical records of patients receiving anti-VEGF treatment for nAMD between January 2015 and March 2019 were retrospectively analyzed. Preoperative and postoperative routine ophthalmological examinations, central macular thickness, duration of inflammation, and follow-up time of the patients with non-infectious IOI following anti-VEGF injection were recorded. Non-infectious IOI was determined in 13 eyes (11 eyes with aflibercept, 2 eyes with ranibizumab) of 1,966 patients who received a total of 12,652 anti-VEGF (4,796 aflibercept and 7,856 ranibizumab) injections. IOI was detected after a mean of 7 injections (2-12 injections). All eyes had both anterior chamber reaction (Tyndall +1/+3) and vitritis (grade 1-3). None of the patients had pain, hypopyon, or fibrin reaction. Visual acuity progressed to baseline levels within 28.3 days. Vitritis continued with a mean of 40 days. All patients recovered with topical steroid therapy. In 11 eyes, injection of the same anti-VEGF agent was continued. No recurrence of IOI was observed in any patients. Non-infectious IOI following intravitreal anti-VEGF injection typically occurs without pain, conjunctival injection, hypopyon, or fibrin and responds well to topical steroid therapy. Visual acuity returns to baseline levels within weeks according to the severity of inflammation.

1 October 2021 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
MKMahmut Kaya
Mahmut Kaya
FÖFerit Hakan Öner
Ferit Hakan Öner
BLBanu Lebe
Banu Lebe
SÖSermin Özkal
Sermin Özkal
SMSüleyman Men
Süleyman Men
ASAli Osman Saatci
Ali Osman Saatci
Intraocular lymphomas are among the rare malignancies that present with a wide variety of clinical manifestations. Differential diagnosis can be very troublesome due to its mimicking nature, insidious disease onset, and partial treatment response to steroids. The most important step in diagnosis is a high index of suspicion. Signs of the disease are now easier to detect using multimodal imaging techniques. In this case series, we reviewed the clinical characteristics of two women aged 70 and 71 years and a 72-year-old man with intraocular lymphoma and described their multimodal imaging findings in detail. Bilateral eye involvement was present in all three cases at our first ophthalmological examination. While the disease first presented with ocular involvement in two of the three cases, ocular involvement was detected seven years after initial heart involvement in one patient. All three patients had diffuse large B-cell lymphomas (one diagnosed with retinal biopsy, one with conjunctival biopsy, and the remaining with stereotactic brain biopsy). Intraocular lymphoma should be diagnosed and treated using a multidisciplinary approach, and we share our experience in this case series.

25 March 2024 in Anatomia, Histologia, Embryologia
Verified
Journal Article
Closed access
YDYasin Demiraslan
Yasin Demiraslan
IGİfTar Gürbüz
İfTar Gürbüz
MÖMehmet Özbek
Mehmet Özbek
OYOzlem SAHAN YAPICIER
Ozlem SAHAN YAPICIER
HKHarun Karaca
Harun Karaca
HÖHakan Öner
Hakan Öner

10 October 2023 in Biology Bulletin
Verified
Journal Article
Closed access
PDF file
MTM. Tatar
M. Tatar
ZPZ. Polat
Z. Polat
JÖJ. Öner
J. Öner
HÖH. Öner
H. Öner
Testicular torsion causes ischemia and free radical formation by obstructing vascular flow caused by complete or partial rotation of the testis. Myricetin is a plant-derived flavonoid with various biological effects, such as potent anti-oxidation and anti-inflammatory properties. The study aims to evaluate the protective effects of myricetin on the apoptosis of testicular germ cells after experimental testicular torsion. Twenty-four Wistar albino rats were divided into four groups; Control, Sham, Torsion group (720 deg torsion for 2 h), and Myricetin group (torsion model was created, and myricetin injection (1.5 mg/kg) was done during seven days). End of the experiment, testis tissues were removed and fixed in Bouin’s solution. Crossman’s triple stain was done to determine the histological changes. Also, 8-OHdG and Caspase-3 immunoreactivities were assessed, and TUNEL staining was done. According to the results, we found that 8-OHdG, Caspase-3 immunoreactivity, and TUNEL-positive cells increased, accompanied by several histopathological changes in the torsion group. In contrast, myricetin significantly attenuated testicular injury by reducing apoptosis and DNA damage. These findings suggest that myricetin protects testes against torsion-induced damage in rats, possibly by reducing oxidative stress and inhibiting apoptosis. Our study provides a theoretical basis for further research into maintaining male reproductive health.

15 January 2021 in Veteriner Hekimler Derneği Dergisi
Verified
Journal Article
Open access
DMDuygu Mutluay
Duygu Mutluay
ÖÖÖzlem Özbey
Özlem Özbey
LKLeyla Kilinç
Leyla Kilinç
JÖJale Öner
Jale Öner
HÖHakan Öner
Hakan Öner
IÜİ̇smail Üstünel
İ̇smail Üstünel
İmplantasyon, embriyonun özel hücreleri olan trofoektoderm ve trophoblast vasıtasıyla uterus dokusuyla bağlantı kurulması ile son bulan bir süreçtir. Başarılı bir implantasyon, plasentasyon ve sonrasında gebeliğin gerçekleşebişmesi için damardan zengin bir endometriyum, koordine olmuş bir damar gelişimi ve plasental villöz damarların genişlemesine gereksinim vardır. Bu bilgiler anjiyogenezin gebeliğin erken dönemleri için önemli fizyolojik bir süreç olduğunu göstermiştir. Prokinetisin ailesinin bir üyesi olan vasküler endoteliyal büyüme faktörü (EG-VEGF) diğer bir adıyla prokinetisin 1 (PROK1) plasentayı da içine alan spesifik endokrin dokular için anjiyogenik bir faktör olarak rapor edilmiştir. Biyolojik aktivitesini iki G protein bağlı reseptör, prokinetisin reseptör 1 (PROKR1) ve prokinetisin reseptör 2 (PROKR2) aracılığı ile gerçekleştirir. Trofoblast invazyonunu kontrol eden PROK1ve PROKR1 plasentada eksprese edilmektedir. Ayrıca, PROK1 plasental anjiyogenezi kontrol eder ve yüksek oranda birinci trimester boyunca eksprese edilmektedir. Çalışmamızda kullanılan dişi fareler, östrus siklusu tayini yapıldıktan sonra, 1 gece erkek fareler ile birlikte bırakılarak gebe kalmaları sağlandı. Vaginal plak (tıkaç) görülen dişiler gebe olarak değerlendirildi. Gebeliğin 1, 2, 3, 4, 5, 6, 7 ve 8. günlerinde alınan uterus doku örneklerinde Western Blot yöntemi kullanılarak PROK1, PROKR1 proteinlerinin ekspresyon analizi yapıldı ve günler arasında bir farklılığın olup olmadığını belirlemek için varyans analizi yöntemi kullanıldı. Çalışmamızda PROK1 ve PROKR1 proteinlerinin gebeliğin ilk 8 günü boyunca eksprese edildiği görüldü. Bu bulgular bize PROK1 ve PROKR1 proteinlerinin erken embriyo gelişimi ve implantasyon sırasında eksprese edildiğini ve bu proteinlerin embriyo gelişiminde önemli roller oynuyor olabileceğini önermiştir.